Clinical applications of recombinant virus-based cancer immunotherapy

Author： Adamina Michel   Daetwiler Silvia   Rosenthal Rachel   Zajac Paul  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.5, Iss.9, 2005-09, pp. : 1211-1224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virus-based therapies for colon cancer

By Morse Michael A  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 12, 2005-12 ,pp. : 1627-1633

Informa Healthcare

Access to resources Recommend Favorite

Targeting autophagy to enhance oncolytic virus-based cancer therapy

By Meng Songshu  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 6, 2013-08 ,pp. : 863-873

Informa Healthcare

Access to resources Recommend Favorite

Recent clinical development of dendritic cell-based immunotherapy for prostate cancer

By Rini Brian  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1729-1734

Informa Healthcare

Access to resources Recommend Favorite

MUC1-based recombinant Bacillus Calmette–Guerin vaccines as candidates for breast cancer immunotherapy

By Yuan Shifang   Shi Changhong   Liu Li   Han Wei  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1037-1048

Informa Healthcare

Access to resources Recommend Favorite

Neutrophils in antibody-based immunotherapy of cancer

By van Egmond Marjolein  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 83-94

Informa Healthcare

Access to resources Recommend Favorite